Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 13Neoplasm Metastasis 4Liver Neoplasms 3Leiomyoma 3Uveal Melanoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Stomach Neoplasms 1Spinal Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neoplasms 1Myoma 1Desmoid Tumors 1Colorectal Cancer Liver Metastases (CRLM) 1Chylous Ascites 1Cholangiocarcinoma 1Blood Loss, Surgical 1Abdominal Neoplasms 1

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Recurrence × Embolization, Therapeutic × Clear all
NCT02587884 2016-03-31

Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH

Eastern Hepatobiliary Surgery Hospital

Phase 1 Unknown
180 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡